OpenAlex
PricingAboutJobs
Log inGet started
Work

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

HTML

Year: 2023
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2023-186636
Authors: Benjamin R Puliafito, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Melanie Ayala Ceja, Christy Sidhu, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Karla Nawaly, Martin S Allen-Auerbach, Jonathan Said, Monica Mead, Sven de Vos, Patricia A. Young, Caspian H. Oliai, Gary J. Schiller, John Timmerman, Antoni Ribas, Yvonne Y Chen, Sarah M. Larson
Institutions: University of California, Los Angeles, Parker Institute for Cancer Immunotherapy, Ronald Reagan UCLA Medical Center, UCLA Medical Center, UCLA Jonsson Comprehensive Cancer Center
Language: English

Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4389220851
Cites:
Cited by: 3
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms